Tricyclic antidepressants (TCAs) and selective serotonin-norepinephrine reuptake inhibitors that are prescribed to treat patients with depression are also known to alleviate chronic neuropathic pain, but the mechanisms are not fully understood.
from JAMA Current Issue http://ift.tt/1OiP0ag
via IFTTT
No comments:
Post a Comment